products

Raw Material Drug Anidulafungin 166663-25-8 for HIV treatment Powder

Basic Information
Place of Origin: China
Brand Name: Senwayer Brand
Certification: ISO, 9001, USP
Model Number: 166663-25-8
Minimum Order Quantity: 10g
Price: Discount is possible if your order is big enough
Packaging Details: 10g, 20g, 50g , 100g, 500g. 1kg, 10kg
Delivery Time: within 2 working days
Payment Terms: T/T in advance, Money Gram, Western Union, Bank Transfer.
Supply Ability: 50KG / Month
Detail Information
CAS: 166663-25-8 Alias: Anidulafungin;Echinocandin B
Apparence: Almost White Crystalline Powder Purity: 99.5%
Function: Anidulafungin Stock: Available
High Light:

pharmaceutical raw material

,

chemical raw material


Product Description

Raw Material Drug Anidulafungin 166663-25-8 for HIV treatment Powder

 

Quick detail


Product Name: Anidulafungin
Synonyms: Anidulafungin;Echinocandin B, 1-(4R,5R)-4,5-dihydroxy-N2-4-(pentyloxy)1,1:4,1-terphenyl-4-ylcarbonyl-L-ornithine-;Anidulafungin(LY303366);Ecalta;Eraxis;LY 303366;LY 303366, Eraxis;1-[(4R,5R)-4,5-dihydroxy-N2-[[4''-(pentyloxy)[1,1'',1''-terphenyl]-4-yl]carbonyl]-L-ornithine]-echinocandin B
CAS: 166663-25-8
MF: C58H73N7O17
MW: 1140.25
EINECS:
Product Categories: Antifungals;API;Inhibitors

 

Anidulafungin​ Introduction


Anidulafungin (brand names: Eraxis (in U.S. and Russia), Ecalta (in Europe)) is a semisynthetic echinocandin used as an antifungal drug. Anidulafungin was originally manufactured and submitted for FDA approval by Vicuron Pharmaceuticals. Pfizer acquired the drug upon its acquisition of Vicuron in the fall of 2005. Pfizer gained approval by the Food and Drug Administration (FDA) on February 21, 2006; it was previously known as LY303366. Preliminary evidence indicates it has a similar safety profile to caspofungin. Anidulafungin has proven efficacy against esophageal candidiasis, but its main use will probably be in invasive Candida infection; it may also have application in treating invasive Aspergillus infection. It is a member of the class of antifungal drugs known as the echinocandins; its mechanism of action is by inhibition of (1→3)-β-D-glucan synthase, an enzyme important to the synthesis of the fungal cell wall.

 

Medical Application API:


Usage Anidulafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class that was reported in 1995 and commercially developed by Eli Lilly. Anidulafungin inhibits the synthesis of β-(1,3)-D-glucan, an essential component of the cell wall of susceptible fungi and is extensively referenced in the literature with over 400 citations.
Usage nucleoside reverse transcriptase inhibitor (NRTI) for HIV treatment in adults
Definition ChEBI: A semisynthetic echinocandin anti-fungal drug. It is active against Aspergillus and Candida species and is used for the treatment of invasive candidiasis.

 

Raw Material Drug Anidulafungin 166663-25-8 for HIV treatment Powder 0

 

Contact Details
Abby Xiang

Phone Number : +8617764031156

WhatsApp : +8617764031156